KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Retained Earnings: 2018-2024

Historic Retained Earnings for Adaptive Biotechnologies (ADPT) over the last 7 years, with Dec 2024 value amounting to -$1.3 billion.

  • Adaptive Biotechnologies' Retained Earnings fell 6.27% to -$1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 billion, marking a year-over-year decrease of 6.27%. This contributed to the annual value of -$1.3 billion for FY2024, which is 13.94% down from last year.
  • According to the latest figures from FY2024, Adaptive Biotechnologies' Retained Earnings is -$1.3 billion, which was down 13.94% from -$1.1 billion recorded in FY2023.
  • Adaptive Biotechnologies' Retained Earnings' 5-year high stood at -$511.6 million during FY2020, with a 5-year trough of -$1.3 billion in FY2024.
  • Moreover, its 3-year median value for Retained Earnings was -$1.1 billion (2023), whereas its average is -$1.1 billion.
  • Data for Adaptive Biotechnologies' Retained Earnings shows a maximum YoY plummeted of 40.51% (in 2021) over the last 5 years.
  • Yearly analysis of 5 years shows Adaptive Biotechnologies' Retained Earnings stood at -$511.6 million in 2020, then tumbled by 40.51% to -$718.9 million in 2021, then dropped by 27.85% to -$919.1 million in 2022, then dropped by 24.51% to -$1.1 billion in 2023, then dropped by 13.94% to -$1.3 billion in 2024.